Symposia: Cellular Immunotherapies other than CAR-T Cells: Basic and Translational
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Bleeding and Clotting, Lymphoid Leukemias, ALL, Translational Research, Hemophilia, Genetic Disorders, Diseases, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Emerging technologies, Biological Processes, Technology and Procedures, Miscellaneous Cellular Therapies, Gene editing
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Bleeding and Clotting, Lymphoid Leukemias, ALL, Translational Research, Hemophilia, Genetic Disorders, Diseases, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Emerging technologies, Biological Processes, Technology and Procedures, Miscellaneous Cellular Therapies, Gene editing
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Ballroom 20AB
(San Diego Convention Center)
Moderators:
Kazusa Ishii, MD, MPH, National Cancer Institute
and
Bernhard Gentner, MD, Ludwig Institute for Cancer Research, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV)
Disclosures:
Gentner: Genenta Science: Consultancy, Current equity holder in publicly-traded company, Honoraria, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties: US10287579B2.
For this session, we have selected six top scoring abstracts for oral presentation that develop novel engineered cell therapy approaches, or that investigate novel cell based delivery approaches.
9:30 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH